Recent studies have explored the integration of artificial intelligence (AI) and radiogenomics to correlate imaging features with molecular markers in clear cell renal cell carcinoma (ccRCC), particularly focusing on mutations in genes such as VHL, PBRM1, and BAP1. This evidence concerns the gene BAP1 and nonpapillary renal cell carcinoma.